Teva Backs Off From Big Acquisitions In 2012, But Isn't Done Spending Just Yet
This article was originally published in PharmAsia News
Executive Summary
Teva brought in Cephalon and a vastly expanded Japanese operation in 2011, and now the company expects to carve out local deals in new markets, execs tell investors during the annual JP Morgan Healthcare Conference.